5KAMEL H K. Male Osteoporosis: new trends in diagnosis and therapy [ J ]. Drugs Aging, 2005, 22 (9) : 741 - 748.
6POLOMBA S, NUMIS F G, MOSSETTI G, et al. Raloxifene administration in post - menopausal women with osteoporosis effect of different Bsm Ⅰ vitamin D receptor genotypes [ J ]. Hun Reprod, 2003, 18(1) : 192 -198.
7SUN L, PENG Y, SHARROW A C, et al. FSH directly regulates bone mass[J]. Cell, 2006, 125:247-260.
8HASE H, ANDO T, ELDEIRY L, et al. TNFα mediates the skeletal effects of thyroid - stimulating hormone [ J]. Proc Natl Acad Sci USA, 2006, 103:12 849 -12 854.
9IQBAL J, SUN L, KUMAR T R, et al. Follicle -stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation [ J]. Proc Natl Acad Sci USA, 2006, 103 : 14 925 - 14 930.
10ZAIDI M. Skeletal remodeling in health and disease [ J ]. Nat Med, 2007, 13:791 -802.
8Koinuma D,Imamura T.Bone formation and inflammation.Nippon Rinsho,2005,63:1523-1528.
9Pogoda P,Priemel M,Rueger JM,et al.Bone remodeling:new aspects of a key process that controls skeletal maintenance and repair.Osteoporos lnt,2005,16 Suppl 2:18-24.
10Christiansen P.The skeleton in primary hyperparathyroidism:a review focusing on bone remodeling,structure,mass,and fracture.APMIS,2001,102 (Suppl):1-52.
